Intermediate-term outcomes after paediatric cardiac extracorporeal membrane oxygenation – what is known (and unknown)

The use of extracorporeal membrane oxygenation in infants and children with cardiac disease who develop refractory cardiogenic shock, cyanosis, or cardiac arrest is increasing. Early mortality in children with cardiac disease who require extracorporeal membrane oxygenation remains an important issue...

Full description

Saved in:
Bibliographic Details
Published in:Cardiology in the young 2011-12, Vol.21 (S2), p.118-123
Main Authors: Costello, John M., Cooper, David S., Jacobs, Jeffrey P., Chai, Paul J., Kirsch, Roxanne, Rosenthal, Tami, Dalton, Heidi J., Graziano, Joseph N., Quintessenza, James A.
Format: Article
Language:English
Subjects:
Cardiac Surgical Procedures - adverse effects
Child
Extracorporeal Membrane Oxygenation - methods
Extracorporeal Membrane Oxygenation - psychology
Follow-Up Studies
Heart Arrest - etiology
Heart Arrest - psychology
Heart Arrest - therapy
Heart Defects, Congenital - mortality
Heart Defects, Congenital - psychology
Heart Defects, Congenital - surgery
Humans
Part 1: A Holistic Approach to Hypoplastic Left Heart Syndrome
Postoperative Complications
Quality of Life
Survival Rate - trends
Time Factors
United States
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The use of extracorporeal membrane oxygenation in infants and children with cardiac disease who develop refractory cardiogenic shock, cyanosis, or cardiac arrest is increasing. Early mortality in children with cardiac disease who require extracorporeal membrane oxygenation remains an important issue, as only 40% of cannulated patients survive to discharge from the hospital. However, it is encouraging that 90% children who are discharged alive from the hospital after extracorporeal membrane oxygenation are still alive at intermediate-term follow-up. Surviving patients are at risk for long-term dysfunction of multiple organ systems related to their underlying cardiac disease, non-cardiac comorbidities, treatment-related complications, and exposure to extracorporeal membrane oxygenation. Among the most important acute complications related to support with extracorporeal membrane oxygenation is injury to the central nervous system, which may contribute to adverse neurodevelopmental outcomes. All of these factors, in turn, influence quality of life. Many survivors remain medically complex related to their underlying cardiac disease, comorbidities, and sequelae of complications acquired over their lifetime. Neurological morbidity clearly plays an important role in approximately one-third of survivors, with significant deficits in approximately 10%. The limited data about quality of life data that are available for survivors of cardiac extracorporeal membrane oxygenation suggests that approximately 15–30% of survivors have at least moderately decreased quality of life. Overall, published data support the ongoing use of support with extracorporeal membrane oxygenation in children with acute cardiac failure, most of whom would die without it. However, programmatic efforts to improve the selection of patients and the preservation of the function of end organs during extracorporeal membrane oxygenation are clearly needed in order to improve long-term outcomes.
ISSN:1047-9511
1467-1107
DOI:10.1017/S1047951111001697